hotspot -WSS

hotspot

author：entertainment 2025-09-30 17:44:09 - browse：211

The Dr. Gary B. and Pamela S. Williams Tower in Summa Health System's Akron Campus — Summa Health

General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech into everyday appointments and rewarding staff for keeping patients healthy might sound alluring. But the firm’s bold experiment is facing hurdles even before it has started as the community served by the health system it hopes to buy is pushing back.

The Health Assurance Transformation Corp., a General Catalyst entity known as HATCo, unveiled plans last month to acquire Akron safety net provider Summa Health. But since the announcement, residents and local officials have raised questions about who the deal benefits, and who gets left behind.

On Thursday, the Mayor of Akron plans to press HATCo’s chief executive, Marc Harrison, who previously led Intermountain Health, on whether his plan is a profit play or a longer-term investment in the community. At the forefront are citizens’ concerns that the deal will drive up costs, eliminate jobs, reduce the quality of care or even shutter one of just two major hospital systems in the area, about a fifth of whose patients are on Medicaid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Welsh Carson private equity firm escapes from FTC antitrust case

hotspot

WSS

How many hemophilia patients actually want gene therapy?

As health system earnings go up, health insurance stocks go down

As billionaires fund anti

Is it ever OK for doctors to lie to their patients?

AI for drug discovery: Experts on separating hype from reality

Sepsis can kill a child within hours. Here's how hospitals are fighting back

knowledge

hotspot

explore

New air purifier tech could be key to improving indoor air quality

Brain technologies pose threats that are all too real, experts warn

Trump demands the U.S. pay no more for drugs than other countries … again

Brain MRIs reveal impact of 'toxic stress' on Black children

New air purifier tech could be key to improving indoor air quality

The creative science of coining drug names

Continuity nursing helped my family in our darkest PICU moments

Male and female sex labels in research insufficient, scientists say

Medical leaders decry Supreme Court decision on affirmative action

Chemotherapy before breast cancer surgery might fuel metastasis

focus

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Most antidepressants don't work on kids, teens, study finds

Crowdfunding for medical bills sidesteps core problem, author says

Black vets could get higher VA benefits if race not used in lung test

Novel spinal cord stimulator treats paralysis without surgery

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

entertainment

explore

focus